Outcome of Board Meeting held on 14th May 2026. The Board approved: 1. Audited Standalone & Consolidated Financial Statements & Results for the Quarter and Year Ended 31st March 2026 2. ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.9 pts less than Nifty Microcap 250 and 3.2 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Chemcrux Enterprises Ltd's Board of Directors met on 14th May 2026 and approved the audited standalone and consolidated financial statements for the quarter and year ended 31st March 2026, as reviewed by the Audit Committee and audited by Naresh & Co., Chartered Accountants. The Board also recommended a final dividend of 10% (Rs. 1/- per share) on equity shares of Rs. 10 each, subject to shareholder approval at the ensuing AGM. Additionally, the Board approved the incorporation of a Section 8 company as a wholly-owned subsidiary to fulfil CSR obligations, with the proposed WOS to be funded via cash subscription of shares.
The dividend recommendation signals a stable financial position. The creation of a CSR-focused wholly-owned subsidiary has no direct impact on the company's financial performance but ensures compliance with corporate social responsibility norms.